Please login to the form below

Not currently logged in
Email:
Password:

solanezumab

This page shows the latest solanezumab news and features for those working in and with pharma, biotech and healthcare.

Lilly partners with AC Immune on tau drug for Alzheimer’s

Lilly partners with AC Immune on tau drug for Alzheimer’s

including Lilly’s own amyloid-targeting solanezumab and lanabecestat – have failed in clinical trials, although the former remains in Lilly’s pipeline.

Latest news

More from news
Approximately 5 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Lilly said that while the study results, ‘including many secondary clinical endpoints, directionally favoured solanezumab, the magnitudes of treatment differences were small’. ... December, where Lilly confirmed it will not pursue regulatory

  • Interview: Mike Hutton, Lilly Interview: Mike Hutton, Lilly

    Lilly's great hope in amyloid beta is now solanezumab, a candidate with a chequered history. ... But Lilly is pressing on with a third late-stage trial, and Dr Hutton was adamant solanezumab remains a priority project for Lilly. .

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics